跳至主要内容
临床试验/CTRI/2021/03/032468
CTRI/2021/03/032468尚未招募2 期

A Randomized Controlled Trial comparing Myoinositol based therapy in combination withMetformin versus Metformin monotherapy on the clinical, metabolic and hormonalparameters in Obese reproductive age women with Polycystic Ovarian Syndrome

Roshan Nazirudeen0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Overweight or obese as defined by a BMI>=23
  • 2. Diagnosed to have polycystic ovarian syndrome according to the Rotterdam criteria by presence of any two out of the following: oligo/anovulation, clinical and/or biochemical evidence of hyperandrogenism, polycystic ovaries by ultrasound.
  • 3. Giving informed consent

排除标准

  • 1. Causes of secondary PCOS including hyperprolactinemia, hypothyroidism, Cushingâ??s syndrome, adrenal and ovarian androgen secreting tumors, patients on medications thought to cause PCOS like valproate.
  • 2. Liver disease or renal impairment
  • 3. Diabetes mellitus
  • 4. Intake of any drugs for PCOS treatment in past 3months
  • 5. Ovarian drilling or any ovarian surgical procedures in the past 6 months
  • 6. Not consenting to the study

研究者

发起方
Roshan Nazirudeen

相似试验